- Home
- » Tags
- » Amifampridine
Top View
- FIRDAPSE Can Cause Seizures
- Preferred Drug List 4-Tier Small Group
- Medicaid List of Covered Drugs (Formulary)
- Emtree Terms Changed in September 2013
- Product Monograph Including Patient Medication Information
- 2020 Medicaid Preapproval Criteria
- FEP 5 Tier Rx Drug Formulary (607) Standard Option
- 3,4-Diaminopyridine Treatment for Lambert-Eaton Myasthenic Syndrome in Adults: a Meta-Analysis of Randomized Controlled Trials
- Atul Kamar Sood, Et Al. V. Catalyst Pharmaceutical Partners, Inc., Et Al
- State and Specialty Pharmacy Drug Reimbursement Rates
- Specialty Pipeline Monthly Update September 2018
- Medicare Model Guidelines Draft V8.0 1 of 97
- Advancing Health Through Innovation: New Drug Approvals 2019
- Amifampridine
- WHO Drug Information Vol. 20, No. 4, 2006
- Firdapse and Ruzurgi
- Pharmacy Medical Necessity Guidelines: Amifampridine (Firdapse®, Ruzurgi®) Effective: January 12, 2021
- Drugs for Rare Diseases: Evolving Trends in Regulatory and Health Technology Assessment Perspectives [Environmental Scan, Issue 42]
- Orange Book Cumulative Supplement 7 July 2021
- Serve You Rx Prior Authorization Information and Drug List
- Appendix A: Perioperative Medication Management
- Oxford Policy Update Bulletin: September 2020
- FEP 5 Tier Managed Rx Drug Formulary (807) Basic Option
- ( 12 ) United States Patent ( 10 ) Patent No .: US 10,793,893 B2 Garovoy Et Al
- Index by Drug Name for Essential Neuropharmacology: a Prescriber’S Guide
- Prior Authorization — Premium
- FIRDAPSE, RUZURGI (Amifampridine) RATIONALE FOR
- Application Number
- VIRGINIA PREMIER MEDALLION 4.0 PRIOR AUTHORIZATION DETAIL September 1, 2021
- 3-Tier Preferred Drug List
- Firdapse, INN-Amifampridine
- 2021 Pacificsource Health Plans Prior Authorization Criteria Last Modified
- Amifampridine) Policy Number: C15969-A
- Amifampridine (Firdapse®, Ruzurgi®) EOCCO POLICY
- Wednesday, February 13, 2019 4:00Pm
- Therapeutic Drug Class
- Zenas, INN-Amifampridine
- Amifampridine (Firdapse , Ruzurgi )
- Wednesday, February 12, 2020 4:00Pm
- Neurology Clinical Trials 2018
- 2018 Annual Report
- Study Protocol